Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 8,060,550 shares of common stock of DocuSign, Inc. by certain existing stockholders of DocuSign, and the representatives of the initial purchasers in a concurrent Rule 144A offering by DocuSign of $575 million aggregate principal amount of 0.50% convertible senior notes due 2023, including $75 million principal amount of convertible notes pursuant to the exercise of the initial purchasers’ option to purchase additional convertible notes. In addition, Davis Polk advised counterparties to capped call transactions in connection with the convertible notes offering. DocuSign’s common stock is listed on the NASDAQ Global Select Market under the symbol “DOCU.”
DocuSign accelerates the process of doing business for companies and simplifies life for their customers and employees by transforming the foundational element of business: the agreement. As the core part of its broader platform for automating the agreement process, DocuSign offers the world’s #1 e-signature solution. DocuSign’s corporate headquarters are in San Francisco, California.
The Davis Polk corporate team included partner Sarah K. Solum and associates Adam H. Whitaker and Ali DeGolia. The Davis Polk equity derivatives team included partner John M. Brandow and associates Katharine O’Banion, Jeffrey H. Smith and Chaoshun (Jeff) Zuo. Partner Rachel D. Kleinberg and associate M. Jared Sanders provided tax advice. Associate Jason J. Bang provided intellectual property and technology advice. Members of the Davis Polk team are based in the Northern California and New York offices.